Cardlytics
CDLX
164 hedge funds and large institutions have $2.62B invested in Cardlytics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 60 reducing their positions, and 41 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0.08% less ownership
Funds ownership: 9.54% → 9.46% (-0.08%)
2% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 60
13% less funds holding
Funds holding: 189 → 164 (-25)
34% less capital invested
Capital invested by funds: $3.99B → $2.62B (-$1.36B)
54% less call options, than puts
Call options by funds: $18.5M | Put options by funds: $39.7M
59% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
CAS Investment Partners
Westport,
Connecticut
|
+$67M |
| 2 |
6CM
683 Capital Management
New York
|
+$56.2M |
| 3 |
Bank of New York Mellon
New York
|
+$39.1M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$25.8M |
| 5 |
Morgan Stanley
New York
|
+$18.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$64.3M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$25.7M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$22.6M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$17.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$15.9M |
CDLX Hedge Fund Activity: Q3 2021 in Review
164 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q3 2021, worth a combined $2.62B — down 34% from $3.99B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of CDLX and 17 opened new positions — a net loss of 24 holders — while 60 trimmed existing stakes and 59 added.
The largest buyer was CAS Investment Partners, adding an estimated $67M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $64.3M sold.
- 164 institutional investors held Cardlytics (CDLX) as of Q3 2021, down from 189 in Q2 2021.
- Funds reported $2.62B of Cardlytics stock for Q3 2021, down 34% quarter-over-quarter.
- 17 funds opened new Cardlytics positions in Q3 2021 and 41 closed out, a net change of -24 holders.
- The largest Cardlytics buyer in Q3 2021 was CAS Investment Partners, an estimated $67M added.
- The largest Cardlytics seller in Q3 2021 was Lord, Abbett & Co, an estimated $64.3M sold.
Based on aggregated 13F filings for Q3 2021.